III期ReSPECT研究已完成入组，该研究旨在预防接受异基因血液和骨髓移植的成人患者发生真菌感染 ReSPECT研究的主要结果预计将于2026年中期公布 英国剑桥--(BUSINESS WIRE)--(美国商业资讯)-- Mundipharma今日宣布，正在进行的全球III期ReSPECT试验已完成患者招募，该试验 ...

New tool helps sponsors measure, manage and minimize the environmental impact of researchWILMINGTON, N.C.--(BUSINESS ...

Clinical Study Led by HS Connect Demonstrates Significant Reduction in HS Symptoms and Improved Quality of Life With Daily ...

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and ...

Pharmaceutical Industry Professional Oliver Patel Will Explore How Companies Can Navigate Risk, Governance, and Copyright Related to Enterprise AIDANVERS, Mass.--(BUSINESS WIRE)--CCC (Copyright ...

Expansion positions Aeris and partners to capture a multibillion-dollar opportunity as more enterprises use cellular-connected extensions of their networksCHICAGO--(BUSINESS WIRE)--Aeris, a global ...

Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on preliminary voting results. The ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on ...

Co-led by Wing Venture Capital and Insight Partners, the financing will scale Chemify’s Chemputation platform and Chemifarm ...

Built on GE HealthCare’s 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leverages proprietary algorithms and proven technologies to ...

First returning adult patient from Phase 1b study recently dosed; additional returning patients being scheduled11-month open-label study will evaluate functional outcomes, safety, muscle composition ...

Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, announced today that it has ...